Home / Germany / Vyne Therapeutics INC
Vyne Therapeutics INC
No short position is open on this share today.
Evolution of the disclosed total
February 19, 2021 today
Open positions
No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.
Get the moves on Vyne Therapeutics INC by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| March 16, 2021 | Worldquant, LLC | 0.00% | |
| March 11, 2021 | Worldquant, LLC | 0.75% | |
| March 9, 2021 | Worldquant, LLC | 0.82% | |
| March 8, 2021 | Worldquant, LLC | 0.74% | |
| March 5, 2021 | Worldquant, LLC | 0.58% | |
| March 3, 2021 | Millennium International Management LP | 0.47% | |
| March 1, 2021 | Millennium International Management LP | 0.59% | |
| February 22, 2021 | Millennium International Management LP | 0.46% | |
| February 19, 2021 | Millennium International Management LP | 0.53% |
Download 9 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Germany
- AUTO1 Group SE 7.92% of the capital sold short
- HelloFresh SE 7.88% of the capital sold short
- Evotec SE 6.81% of the capital sold short
- TUI AG 6.74% of the capital sold short
- Quantum Computing Inc 6.72% of the capital sold short
- PVA TePla AG 6.48% of the capital sold short
- LANXESS Aktiengesellschaft 5.94% of the capital sold short
- Odyssey Marine Exploration, Inc. 5.60% of the capital sold short
- Zalando SE 5.35% of the capital sold short
- Puma SE 5.14% of the capital sold short
- RENK Group AG 5.08% of the capital sold short
- TAG Immobilien AG 5.04% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Vyne Therapeutics INC, source Bundesanzeiger, data as at March 16, 2021, https://www.quivad.com/action/vyne-therapeutics-inc